In the Media
Grant Supports Aging Research
The MDI Biological Laboratory has announced that the U.S. Department of Health and Human Services has awarded a grant in the amount of $373,500 per year for five years to Aric Rogers to support his research on the cellular and molecular mechanisms governing aging.
BAR HARBOR — The MDI Biological Laboratory has announced that the U.S. Department of Health and Human Services has awarded a grant in the amount of $373,500 per year for five years to Aric Rogers to support his research on the cellular and molecular mechanisms governing aging.
The understanding of these mechanisms that will be gained from this research holds the prospect of contributing to new therapies to delay or offset the effects of age-related diseases and conditions, and in particular the loss of muscle mass that occurs with advancing years — a condition called sarcopenia.
“This grant will allow Aric to continue with his important work of deciphering the pathways that govern aging,” said Hermann Haller, president of the MDI Biological Laboratory. “Science is closing in on the ability to extend healthy lifespan, and this grant will bring us even nearer to achieving that goal.”
The grant has special implications for the health of the residents of Maine, which is the state with the nation’s oldest population.
“As the state with the oldest median age in the nation, Maine has a unique responsibility to take a leadership role in helping our seniors stay healthy as they age,” said U.S. Sens. Susan Collins, the chairman of the Senate aging committee, and Angus King in a joint statement. “Dr. Rogers’ research is important to understanding the factors that lead to age-related conditions and to helping innovators develop therapies for seniors that could reduce or postpone their symptoms.”
In his career in aging biology, Rogers has focused on the study of the genetic pathways that regulate dietary restriction (DR), or a reduction in calories without malnutrition.
The grant will support further research on Rogers’ earlier findings, which showed that muscle may be preferentially protected — or “privileged” — under conditions of DR. Rogers believes that DR promotes the replacement of muscle components by activating genes that control muscle structure and function.
He hypothesizes that this is nature’s way of ensuring that an organism is able to maintain the muscle strength and functionality needed to continue to forage for food in the face of a scarcity of nutrients. His discovery may have applications for the treatment of sarcopenia, or the muscle wasting that is a natural part of aging.
“One of the greatest health risks of aging is frailty, which is caused by loss of muscle mass and integrity,” Rogers said. “By gaining a better understanding of the mechanisms by which muscle tissue is maintained under conditions of DR, we can inform efforts to develop drugs that promote the function and maintenance of skeletal muscle with age.”
Sarcopenia is one of the most important causes of functional decline and loss of independence in older adults. Though it typically begins in the thirties, it starts to accelerate around age 75 and by the time an individual has reached the eighties can result in the loss of up to 50 percent of muscle mass.
The grant will leverage powerful, state-of-the art genetic tools, many developed in Rogers’ laboratory, to further elucidate muscle-specific responses to DR, which are not well understood.
View Original Article